Literature DB >> 30657946

Unique clinical features of cryptococcal meningitis among Chinese patients without predisposing diseases against patients with predisposing diseases.

Lijun Xu1,2, Xinyue Zhang3, Yongzheng Guo1,2, Ran Tao1,2, Xiahong Dai4, Zongxing Yang5, Ying Huang1, Biao Zhu1,2, Yan Xu1.   

Abstract

The clinical features of cryptococcal meningitis (CM) in patients without predisposing diseases (PD) remain unclear. In sum, 162 of the 167 patients without PD and 162 of the 309 patients with PD were enrolled after propensity score matching. Demographic characteristics, symptoms, blood, and cerebrospinal fluid (CSF) characteristics were compared between the two groups. Kaplan-Meier curves and a Cox proportional hazards model were used to assess the factors associated with 10-week mortality. In total, approximately 35.1% of CM patients were without PD. CM patients without PD had blood profiles of higher white blood cells (WBC) [8.9(6.7-11.0) × 109/l], hemoglobin (128.4 ± 20.9 g/l), platelets [(226.2 ± 64.1) × 109/l], and serum albumin (41.2 ± 5.8 g/l) (all P ≤ .001) and CSF profiles of lower glucose (2.0 ± 1.2 mmol/l), pleocytosis [65.0 (18.0-160.0) × 106/l] and higher total protein [0.9 (0.7-1.4)g/l] (all P < .05). CM patients without PD had lower Cryptococcus culture positivity in CSF (62.5% vs. 74.1%, P = .039) but higher 2-week of CSF culture sterilization rates (69.4% vs. 51.3%, P = .031). The overall 10-week survival rate was 84.7% in patients without PD and 81.1% in patients with PD (Log-rank P = .439). CSF glucose <1.5 mmol/l, CSF fungal burden >20 cells/high power field and treatment lacking amphotericin B had a 3-4 times higher risk of death in patients without PD, whereas serum albumin <35 g/l, CSF glucose < 1.5 mmol/l, and CSF WBC <55 × 106 cell/l were risk factors for patients with PD. CM patients without PD had unique blood and CSF profiles, especially, had lower Cryptococcus culture positivity in CSF, and higher 2-week CSF culture sterilization. Low CSF glucose levels, higher fungal burden, and treatment without amphotericin B were risk factors for 10-week mortality.
© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  clinical feature; cryptococcal meningitis; predisposing disease; prognosis

Year:  2019        PMID: 30657946     DOI: 10.1093/mmy/myy154

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  4 in total

1.  AIDS-associated Talaromyces marneffei central nervous system infection in patients of southwestern China.

Authors:  Yu-Ye Li; Rong-Jing Dong; Samip Shrestha; Pratishtha Upadhyay; Hui-Qin Li; Yi-Qun Kuang; Xin-Ping Yang; Yun-Gui Zhang
Journal:  AIDS Res Ther       Date:  2020-05-26       Impact factor: 2.250

2.  Differences in cytokine and chemokine profiles in cerebrospinal fluid caused by the etiology of cryptococcal meningitis and tuberculous meningitis in HIV patients.

Authors:  Lijun Xu; Yufan Xu; Yanghao Zheng; Xiuming Peng; Zongxing Yang; Qing Cao; Dairong Xiang; Handan Zhao
Journal:  Clin Exp Immunol       Date:  2021-08-08       Impact factor: 5.732

3.  Chemokine and Cytokine Cascade Caused by Skewing of the Th1-Th2 Balance Is Associated with High Intracranial Pressure in HIV-Associated Cryptococcal Meningitis.

Authors:  Lijun Xu; Yongzheng Guo; Yizhou Zhao; Yufan Xu; Xiuming Peng; Zongxing Yang; Ran Tao; Ying Huang; Yan Xu; Yaokai Chen; Biao Zhu
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

4.  Surgical treatment and operation time in human immunodeficiency virus-negative cryptococcal meningitis.

Authors:  Jie Zhao; Xiang Zhao; Shaobo Yang; Shuying Miao; Ying Liu
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.